国产精品国产三级区别第一集,亚洲精品国产成人,精品人妻无码一区二区三区,人妻熟妇乱又伦精品视频

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點(diǎn)擊次數(shù):3318

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報(bào)道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
99热最新成人国产精品| 人妻中出无码一区二区三区| 日本强伦姧人妻一区二区| 国产美女被爽到高潮免费A片| 国产51麻豆二区精品av视频| 精品亚洲成a人在线观看| 疯狂三人交性欧美| 玩弄放荡人妻一区二区三区| 欧美色综合天天久久综合精品| 精品亚洲国产成人蜜臀AV| 向风而行免费观看完整版| 中文人妻AV久久人妻水蜜桃| 国产午夜三级一区二区三| 欧美大片18禁aaa免费视频| 欧美巨大乳bbwvideos| 日本WV一本一道久久香蕉| 激情97综合亚洲色婷婷五| 野花日本韩国视频免费8| 人妻换人妻互换a片爽电影| 99久久久精品免费观看国产| 久久久久久精品久久久| 亚洲日韩在线中文字幕综合| 久久99国产精品久久99| 狠狠综合久久AV一区二区| 国自产拍偷拍精品啪啪模特| 野花香高清视频在线观看免费| 性裸交A片一区二区三区| 欧美日韩人妻精品一区二区三区| 香蕉AV福利精品导航| 精品无码中文视频在线观看 | 歪歪爽蜜臀AV久久精品人人槡| 久久夜色撩人精品国产小说| 免费a级毛片无码免费视频| 久久精品国产亚洲av水果派| 亚洲成av人综合在线观看| 男女作爱免费网站| 色窝窝无码一区二区三区| 人妻无码αv中文字幕久久琪琪布| 久久久无码中文字幕久... | 中文字幕久久久人妻无码| 国产在线精品国自产拍影院同性|